FDA Clears New Disposable Insulin Patch Pump For Patients With T1D and T2D
Drug Topics
SEPTEMBER 4, 2024
Embecta’s new patch pump offers a larger insulin reservoir to better accommodate for the needs of patients with type 2 diabetes (T2D).
Sat.Aug 31, 2024 - Fri.Sep 06, 2024
500 
Pharma’s ‘it’ therapy — a new drug class gaining steam
PharmaVoice
SEPTEMBER 4, 2024
More companies are investing in protein degraders, which leverage a unique approach to harnessing the immune system in cancer, neurological diseases and more.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
New Perspectives in CML Management: Personalized Approaches and Adaptive Strategies
Pharmacy Times
SEPTEMBER 5, 2024
Optimizing outcomes for patients with chronic myeloid leukemia (CML) requires personalized treatment, adaptive dosing, and precise genetic insights.
Missouri resident who had no contact with animals tests positive for bird flu
STAT
SEPTEMBER 6, 2024
This is a developing story and will be updated. A person in Missouri who didn’t report any contact with animals has tested positive for H5 bird flu, the state’s Department of Health and Senior Services and the Centers for Disease Control and Prevention said Friday. It’s not yet clear if the person was infected with the same virus strain that’s causing the ongoing outbreak among dairy cattle.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Clears First Digital Therapeutic for Treatment of Generalized Anxiety Disorder
Drug Topics
SEPTEMBER 4, 2024
DaylightRX from Big Health is a digital formulation of cognitive behavioral therapy and is available by prescription only.
FDA adcomm reform talks heat up
PharmaVoice
SEPTEMBER 3, 2024
As the agency considers eliminating adcomm votes from the approval process, members vie to have their voices heard.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
In a first, living mice are made transparent
STAT
SEPTEMBER 5, 2024
When a dye called tartrazine is added to food, it creates a bright yellow hue often associated with lemon-flavored candy. But when mixed with a little water and daubed on the skin of mice, the dye makes their skin nearly transparent. Researchers reported the new use for the common food dye today in the journal Science. The technique creates a fresh opportunity for researchers to understand what is going on under the skin of a live animal, which could eventually allow them to study the inne
FDA Roundup: Novavax COVID-19 Vaccine, First Digital Therapeutic for GAD
Drug Topics
SEPTEMBER 6, 2024
Check out important updates from the FDA for the week of September 2.
What 3 layoff stories reveal about pharma’s troubles
PharmaVoice
SEPTEMBER 6, 2024
The factors driving the industry’s layoffs — and what could help turn the tide.
Pharmacists Can Counsel Pregnant Individuals Seeking Iron Supplementation
Pharmacy Times
SEPTEMBER 5, 2024
There is no significant impact on maternal or infant health outcomes when taking an additional iron supplement
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Trying to time your seasonal vaccines just right? There are no easy answers, but here are some factors to consider
STAT
SEPTEMBER 4, 2024
With fall coming into view, public health officials across the country are turning to the annual task of persuading legions of Americans to get vaccinated against some combination of influenza, Covid-19, and respiratory syncytial virus, three bugs that sicken mass numbers of people over the winter months, often overwhelming hospitals and health care delivery in the process.
NCPA Calls on CMS to Establish PBM Protection for Independent Pharmacies
Drug Topics
SEPTEMBER 5, 2024
As Medicare open enrollment begins, the NCPA is urging CMS to facilitate appropriate PBM contracting for pharmacies in the upcoming plan year.
SCAN embraces 'rebels with a cause' founding in new brand identity
Fierce Healthcare
SEPTEMBER 5, 2024
SCAN Group is refreshing its visual identity, building its new look around honoring the "rebels with a cause" that founded the company and who continue to inspire its work. | SCAN Group is refreshing its visual identity, building its new look around honoring the "rebels with a cause" that founded the company and who continue to inspire its work.
FDA Approves Sparsentan, With Data Indicating Slowing of Kidney Function Decline in IgA Nephropathy
Pharmacy Times
SEPTEMBER 6, 2024
Full traditional approval follows accelerated approval of the medication last year.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Doctors use problematic race-based algorithms to guide care every day. Why are they so hard to change?
STAT
SEPTEMBER 3, 2024
Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston, she had seen hundreds of kids with suspected urinary tract infections. Each time, she’d turn to a calculator, used by all Boston Children’s Hospital clinicians, to judge the youngest childrens’ risk. Did the infant have a high fever?
Immunization Roundup: Updated COVID-19 Vaccines, Mpox Approval, and More
Drug Topics
SEPTEMBER 2, 2024
Catch up on important immunization news from the month of August.
China detains AstraZeneca workers in data, imports probe
pharmaphorum
SEPTEMBER 5, 2024
A "small number" of AstraZeneca employees have been detained in China in an investigation into suspected data privacy and drug import breaches
Study: Shingles Could Increase Risk of Cognitive Decline
Pharmacy Times
SEPTEMBER 6, 2024
Individuals with a history of shingles was significantly and independently connected with a 20% higher risk of for subjective cognitive decline.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Opinion: Letting funding for the All of Us research program lapse will cost the U.S. far more than it saves
STAT
SEPTEMBER 3, 2024
I was in high school when I first encountered the ruthlessness of the number one killer in the U.S. A close friend of mine, then only 16 years old, witnessed his father having a heart attack while checking the mail. Despite desperate attempts at CPR on the driveway, he wasn’t able to save his dad, a seemingly healthy man in his early 40s. That event put me on a path to become a cardiologist.
RedSail Technologies and the RxCash+ Tool
Drug Topics
SEPTEMBER 4, 2024
Kristen Hartzell, PharmD, Vice President of Clinical Services, RedSail Technologies, sat down with Drug Topics to discuss the RxCash+ tool designed to achieve fairer pricing on cash prescriptions for pharmacies and patients.
American Medical Association slams pay cut, G-codes in proposed Medicare pay rule for doctors
Fierce Healthcare
SEPTEMBER 6, 2024
In its comments to the Centers for Medicare and Medicaid Services (CMS) on the draft CY2025 Medicare physician fee schedule (PFS), the American Medical Association badgered CMS on its pro | The American Medical Association submitted its comment letter to CMS on its draft CY2025 Medicare physician fee schedule. At issue was the 2.
IVIG Shows Promise as Therapy in Patients With Recurrent Implantation Failure
Pharmacy Times
SEPTEMBER 5, 2024
Intravenous immunoglobulin (IVIG) therapy was found to have statistically significant positive effects on live birth rates, implantation rate, and other indicators.
STAT+: Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades
STAT
SEPTEMBER 3, 2024
Kathy Giusti was diagnosed with multiple myeloma in 1996, when she was a 37-year-old executive at the drug company G.D. Searle. She was told she had three years to live. Twenty-eight years later, Giusti, 65, is thriving. One reason is the patient advocacy group she founded in 1998: the Multiple Myeloma Research Foundation. The group has raised more than $600 million for research, launched nearly 100 clinical trials, and helped bring more than 15 new drugs to market.
The Unyielding Grip of Fentanyl on America's Streets: A Pharmacist's Perspective
Drug Topics
SEPTEMBER 3, 2024
Independent pharmacists, health care providers, community leaders, and law enforcement must all work together to address the fentanyl epidemic.
Big Pharma is often media shy. Merck’s chief comms officer is hoping to change that.
PharmaVoice
SEPTEMBER 5, 2024
Cristal Downing is helping Merck & Co. buck pharma’s zipped-lip status quo and usher in a “new era” of openness, transparency and “overt communication.
Staying Up to Date With Routine Vaccinations is Crucial to Slowing Spread, Expert Says
Pharmacy Times
SEPTEMBER 5, 2024
Lauren Posteraro, PharmD, a pharmacist with AHN, discusses how misinformation and access to technology can contribute to vaccine hesitancy.
Moderna reports encouraging results on its mpox vaccine, as outbreaks in Africa spread
STAT
SEPTEMBER 4, 2024
The emergence of a second mpox outbreak in which the virus is spreading from person-to-person, as well as a sharp increase in overall cases of the disease in several African countries, is straining the world’s capacity to make and distribute vaccine to battle the threat. New options are needed, and a study published Wednesday suggests another may be on the horizon.
FDA Approves Updated Novavax COVID-19 Vaccine
Drug Topics
SEPTEMBER 3, 2024
The protein-based vaccine includes a monovalent component corresponding to the Omicron variant JN.1 strain.
A plucky biotech threatening Pfizer’s grip on the Prevnar vaccine market
PharmaVoice
SEPTEMBER 4, 2024
Results from Vaxcyte’s clinical pneumococcal vaccine study showed the smaller company could take on Pfizer’s legendary blockbuster.
CDC Recommends Preventative Action Amid Rising Cases of West Nile Virus
Pharmacy Times
SEPTEMBER 2, 2024
Cases have been detected in 33 US states so far this year, and the virus has recently hospitalized the former Chief Medical Advisor to the President of the US Anthony Fauci.
STAT+: Vor Biopharma’s ‘shielded’ transplant delays relapse in leukemia patients
STAT
SEPTEMBER 5, 2024
A CRISPR-augmented stem cell transplant that protects healthy cells from the toxic effects of anti-cancer medicines has shown preliminary evidence that it can delay relapse in patients with an aggressive form of leukemia, its maker Vor Biopharma said Thursday. In the early stage study, eight of 10 patients with high-risk acute myeloid leukemia remain in remission after receiving a transplant with the Vor therapy, called trem-cel, followed by maintenance treatment with intensified doses of
Abbott’s OTC Lingo CGM for Wellness Now Available
Drug Topics
SEPTEMBER 6, 2024
Lingo offers users a real-time glucose graph, a metric to track glucose spikes, food and activity logging, personal recommendations, and challenges to motivate healthy behaviors.
Providers, vendors building health AI have 'shared responsibility' to ensure safe adoption industrywide
Fierce Healthcare
SEPTEMBER 6, 2024
BOSTON—There’s no shortage of providers and vendors working to develop and deploy artificial intelligence in healthcare—but not all who are delivering care are in a position to make use of these no | Healthcare AI has a tough battle on adoption, trust and responsible use, particularly among organizations lacking in-house tech expertise. Whether it's a vendor or another health system, stakeholders must be prepared to help their peers along the way, experts say.
Let's personalize your content